5.46 - 5.56
4.95 - 8.28
1.7K / 2.4K (Avg.)
-276.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.59%
Revenue growth similar to METSB.HE's 4.59%. Walter Schloss would see if both companies share industry tailwinds.
179.92%
Gross profit growth similar to METSB.HE's 179.92%. Walter Schloss would assume both firms track common industry trends.
42.16%
EBIT growth similar to METSB.HE's 42.16%. Walter Schloss might infer both firms share similar operational efficiencies.
42.16%
Operating income growth similar to METSB.HE's 42.16%. Walter Schloss would assume both share comparable operational structures.
-20.26%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-21.30%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-21.30%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
1.35%
Share count expansion well above METSB.HE's 1.35%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.35%
Diluted share count expanding well above METSB.HE's 1.35%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-157.58%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-329.13%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-26.92%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-26.92%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-29.81%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-146.57%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-146.57%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-152.08%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
119.59%
Similar net income/share CAGR to METSB.HE's 119.59%. Walter Schloss would see parallel tailwinds or expansions for both firms.
119.59%
5Y net income/share CAGR similar to METSB.HE's 119.59%. Walter Schloss might see both on parallel mid-term trajectories.
-15.03%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-19.10%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
76.91%
AR growth well above METSB.HE's 76.91%. Michael Burry fears inflated revenue or higher default risk in the near future.
6.35%
Inventory growth well above METSB.HE's 6.35%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
0.42%
Similar asset growth to METSB.HE's 0.42%. Walter Schloss finds parallel expansions or investment rates.
-0.00%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
2.74%
Debt growth far above METSB.HE's 2.74%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
0.85%
SG&A growth well above METSB.HE's 0.85%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.